Stuart B. Levy, M.D.

Affiliations: 
Molecular Biology and Microbiology Tufts University, Boston 
Area:
Antimicrobial resistance
Website:
http://www.tuftsmedicalcenter.org/apps/TuftsFindAPhysician/PhysicianDetail.aspx?OID=1921
Google:
"Stuart Levy"
Bio:

Levy has studied mechanisms of antibiotic resistance in bacteria from the 1960s to the 2000s. He was President of the American Society of Bacteriology in 1998-99, and founded the Center for Adaptation Genetics and Drug Resistance at Tufts. He won the 2012 Abbott-ASM Lifetime Achievement Award.

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Molina-Quiroz RC, Silva-Valenzuela C, Brewster J, et al. (2018) Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic Escherichia coli. Mbio. 9
McNamara PJ, Levy SB. (2016) Triclosan: An Instructive Tale. Antimicrobial Agents and Chemotherapy
Honeyman L, Ismail M, Nelson ML, et al. (2015) Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline. Antimicrobial Agents and Chemotherapy. 59: 7044-53
Dalhoff AA, Levy SB. (2015) Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern. International Journal of Antimicrobial Agents. 45: 564-7
Warner DM, Duval V, Levy SB. (2013) The contribution of PmrAB to the virulence of a clinical isolate of Escherichia coli. Virulence. 4: 634-7
Levy SB, Marshall BM. (2013) Honeybees and tetracycline resistance. Mbio. 4: e00045-13
Warner DM, Yang Q, Duval V, et al. (2013) Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China. Antimicrobial Agents and Chemotherapy. 57: 1935-7
Marshall BM, Robleto E, Dumont T, et al. (2012) The frequency of antibiotic-resistant bacteria in homes differing in their use of surface antibacterial agents. Current Microbiology. 65: 407-15
Lister IM, Raftery C, Mecsas J, et al. (2012) Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrobial Agents and Chemotherapy. 56: 1120-3
Lichtenstein SJ, De Leon L, Heller W, et al. (2012) Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat. Journal of Pediatric Ophthalmology and Strabismus. 49: 88-97
See more...